ANXA6 and muscular dystrophy: Promisingly, recombinant annexin A6 injected into 5XFAD and APP-NLGF knock-in mouse brains shows the ability to bind to the membranes of DNs around amyloid plaques suggesting that, like in muscular dystrophy, annexin A6 protein could be investigated as a therapeutic.